Comprehensive Care Program for Type 1 Diabetes Blood Sugar Control
Tests a team-based care program with technology, education and peer support in type 1 diabetes.
Plain-language title generated from the registry record
Registry title: Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
Key facts
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Luoyang, Nanjing, Shenyang, and Shenzhen, ChinaSee the 10 sites
Where in China
- Department of Endocrinology and Metabolism, Peking University People's HospitalBeijing, ChinaTaking people
- Department of Endocrinology, Beijing Tongren Hospital, Capital Medical UniversityBeijing, ChinaTaking people
- Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South UniversityChangsha, ChinaTaking people
- Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan UniversityChengdu, ChinaTaking people
- Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, ChinaTaking people
- Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child HealthHangzhou, ChinaTaking people
- Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and TechnologyLuoyang, ChinaTaking people
- Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, ChinaTaking people
- Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical UniversityShenyang, ChinaTaking people
- Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen UniversityShenzhen, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Second Xiangya Hospital of Central South University
- Trial code
- NCT07097805
- Record updated
- 31 July 2025
- Original description
The GLITTER study is comprised of four key components: Team, Technology, Education, and Peer Resources. The aim of the GLITTER Study is to improve the metabolic control rate in patients with type 1 diabetes through a comprehensive management approach.Read full original descriptionShow less
Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
The GLITTER study is comprised of four key components: Team, Technology, Education, and Peer Resources. The aim of the GLITTER Study is to improve the metabolic control rate in patients with type 1 diabetes through a comprehensive management approach.
Inclusion: Patients with type 1 diabetes of all age groups, regardless of disease duration; The diagnosis criteria for type 1 diabetes are met by fulfilling any one point from the first two criteria plus any one point from the third criterion; Clinically diagnosed as Type 1 Diabetes by a specialist physician; Meet any one of the following criteria:; Age of onset <15 years B. No obesity at the time of onset C. diabetic ketoacidosis onset D. Maximum random C-peptide <200 pmol/L; Meet any one of the following criteria:; Initiation and continuation of insulin therapy after diagnosis (excluding pancreas or islet transplantation) B. Positive for islet cell antibodies.